CRCA vs. KORU
CRCA (ProShares Ultra CRCL) and KORU (Direxion Daily South Korea Bull 3X Shares) are both Leveraged Equities funds. CRCA is actively managed, while KORU is passively managed. At a 0.31 correlation, their price movements are largely independent. CRCA charges 0.95%/yr vs 1.29%/yr for KORU.
Performance
CRCA vs. KORU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -25.37% return, which is significantly lower than KORU's 559.14% return.
CRCA
- 1D
- -20.86%
- 1M
- -48.25%
- YTD
- -25.37%
- 6M
- -39.99%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
KORU
- 1D
- -2.29%
- 1M
- 92.47%
- YTD
- 559.14%
- 6M
- 689.29%
- 1Y
- 2,160.10%
- 3Y*
- 132.56%
- 5Y*
- 23.42%
- 10Y*
- 19.62%
CRCA vs. KORU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -25.37% | -81.81% |
KORU Direxion Daily South Korea Bull 3X Shares | 559.14% | 117.99% |
Correlation
The correlation between CRCA and KORU is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. KORU — Risk / Return Rank
CRCA
KORU
CRCA vs. KORU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Direxion Daily South Korea Bull 3X Shares (KORU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | KORU | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 17.63 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.28 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.25 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.47 | 0.13 | -0.59 |
Drawdowns
CRCA vs. KORU - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, roughly equal to the maximum KORU drawdown of -95.79%. Use the drawdown chart below to compare losses from any high point for CRCA and KORU.
Loading charts...
Drawdown Indicators
| CRCA | KORU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -95.79% | +1.77% |
Max Drawdown (1Y)Largest decline over 1 year | — | -61.39% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -73.71% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -93.35% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.79% | — |
Current DrawdownCurrent decline from peak | -87.98% | -5.39% | -82.59% |
Average DrawdownAverage peak-to-trough decline | -69.26% | -57.53% | -11.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 19.33% | — |
Volatility
CRCA vs. KORU - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | KORU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 60.18% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 110.71% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 196.79% | 124.15% | +72.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.79% | 85.11% | +111.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.79% | 79.91% | +116.88% |
CRCA vs. KORU - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is lower than KORU's 1.29% expense ratio.
Dividends
CRCA vs. KORU - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 2.32%, more than KORU's 0.14% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 2.32% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KORU Direxion Daily South Korea Bull 3X Shares | 0.14% | 0.89% | 4.10% | 2.55% | 0.48% | 0.76% | 0.01% | 0.93% | 1.40% | 3.59% |
Frequently Asked Questions
CRCA and KORU have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CRCA is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CRCA is cheaper with a 0.95% expense ratio, compared with 1.29% for KORU.
CRCA has the higher dividend yield at 2.32%, compared with 0.14% for KORU.
They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for CRCA and 1.29% for KORU.
Find the right allocation for CRCA and KORU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer